Journal of Open Innovation: Technology, Market, and Complexity

Table 7 Manager panel’s ranking of factors that influence the value of a licensing deal (Arnold et al. 2002)

From: Valuations using royalty data in the life sciences area—focused on anticancer and cardiovascular therapies

Rank	Driver	Score^a
1	Phase of molecule	1.13
2	Therapeutic area	1.56
3	Type of agreement	1.94
4	Scope of agreement	1.94
5	Type and reputation of buyer	1.94
6	Type of molecule	2.19

^aScores are ranked from 1 (most important) to 3 (least important)

Back to article page